Otsuka Holdings Co Ltd (Otsuka) develops, manufactures, and sells pharmaceuticals, nutraceuticals, consumer products, and other businesses through its subsidiaries. The company's focus on R&D, business performance of pharmaceutical segment, and established presence are its strengths, even as a decline in net working capital could be a cause for concern to the company. Otsuka could benefit from market potential for acute myeloid leukemia, increasing incidence of cardiovascular diseases and strategic initiatives. However, increasing competition, strict regulatory standards, and rapid technological changes could affect the company’s growth prospects in the long run.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer